2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart Eur Heart J 2021
Because the data came from prescribing records rather than pharmacy dispensing records, researchers cannot confirm patients actually took their medication as prescribed throughout follow-up
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma
"We have to look good, we have to sound good, we have to be strong but not too strong, we have to be vulnerable but not too weak
For people living with obesity and MASH, at present, the authors recommend the use of tirzepatide as first line treatment, but note the Phase III ESSENCE trial, not included in the present algorithm because it was published after January, 2025, showed that semaglutide was associated with a significant improvement in MASH and liver fibrosis similar to tirzepatide
Helmstdter J, Keppeler K, Kster L, Munzel T, Daiber A, Steven S